1Gleissner C, Kaesser U, Dehne F, et al. Temporomandibular joint function in patients with longstanding rheumatoid arthritis-I. Role of periodontal status and prosthetic care-A clinical study. Eur J Med Res,2003,8(3):98
2Yamakawa M, Ansai T, Kasai S, et al. Dentition status and temporomandibular joint disorders in patients with rheumatoid arthritis. Cranio,2002,20(3):165
3Voog U, Alstergren P, Eliasson S,et al. Inflammatory mediators and radiographic changes in temporomandibular joints of patients with rheumatoid arthritis. Acta Odontol Scand,2003,61(1):57
4Kopp S, Alstergren P. Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis. Mediators Inflamm,2002,11(4):211
5Bayar N, Kara SA, Keles I, et al. Temporomandibular joint involvement in rheumatoid arthritis:A radiological and clinical study. Cranio,2002,20(2):105
6Melchiorre D, Calderazzi A, Maddali Bongi S, et al. A comparison of ultrasonography and magnetic resonance imaging in the evaluation of temporomandibular joint involvement in rheumatoid arthritis and psoriatic arthritis. Rheumatology (Oxford),2003,42(5):673
1Gleissner C,Kaesser U,Dehne F,et al.Temporomandibu-lar joint function in patients with longstanding rheumatoid ar-thritis-I.Role of periodontal status and prosthetic care-a clinical study[J].Eur J Med Res,2003,8(3):98-108.
2Yamakawa M,Ansai T,Kasai S,et al.Dentition status and temporomandibular joint disorders in patients with rheuma-toid arthritis [J].Cranio,2002,20(3):165-171.
3Thompson PA,Murry D J,Rosner GL,et al.Methotrexate pharmacokinetics in infants with acute lymphoblastie leuke-mia[J].Cancer Chemother Pharrnaeol,2007,59(6):847-853.
4Choi HK,Seeger JD,Kuntz KM,et al.A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis[J].Arthritis Rheum,2000,43(10):2316-2327.
5Barbieri M,Wong JB,Drummond M,et al.The cost effec-tiveness of infliximab for severe treatment-resistant rheuma-toid arthritis in the UK [J].Pharmacoeconomics,2005,23(6):607-618.
6Blackburn MR,Aldrich M,Volmer JB,et al.The use of enzyme therapy to regulate the metabolic and phenotypic consequences of adenosine deaminase deficiency in mice.Differential impact on pulmonary and immunologic abnormal-ities[J].J Biol Chem,2000,275(41):32114-32121.
7Hershfield MS,Kredich NM,Ownby DR,et al.In vivo in-activation of erythrocyte S-adenosylhomocysteine hydrolase by 2:deoxyadenosine in adenosine deaminase-deficient pa-tients[J].J Clin Invest,1979,63(4):807-811.
8Donofrio J,Coleman MS,Hutton J J,et al.Overproduction of adenine deoxynucleosides and deoxynucletides in adeno-sine deaminase deficiency with severe combined immunodefi-ciency disease [J].J Clin Invest,1978,62(4):884-887.
9Halazonetis TD,Gorgoulis VG,Bartek J.An oneogene-in-duced DNA damage model for cancer development[J].Sci-ence,2008,319(5868):1352-1355.
10Teramachi J,Kukita A,Li Y J,et al.Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflam-matory bone destruction in adjuvant-induced arthritis [J].Lab Invest,2001,91(5):719-731.
